Drugs / LM001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03535103 | Jun 2018 → Dec 2019 | female infertility | Alphamab Jilin Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LM001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03535103 ↗ |
| Modality | Protein / enzyme biologic | “LM001 is a recombinant human Follicle Stimulating Hormone (r-hFSH) Injection” NCT03535103 ↗ |
| Route | Subcutaneous | “both given subcutaneously” NCT03535103 ↗ |